{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:26:54Z","timestamp":1792506414285,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007771","name":"\u015al\u0105ski Uniwersytet Medyczny","doi-asserted-by":"publisher","award":["KNW-1-168\/K\/7\/K"],"award-info":[{"award-number":["KNW-1-168\/K\/7\/K"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The tissue metabolomic characteristics associated with endometrial cancer (EC) at different grades were studied using high resolution (400\u00a0MHz) magic angle spinning (HR-MAS) proton spectroscopy. The metabolic profiles were obtained from 64 patients (14 with grade 1 (G1), 33 with grade 2 (G2) and 17 with grade 3 (G3) tumors) and compared with the profile acquired from 10 patients with the benign disorders. OPLS-DA revealed increased valine, isoleucine, leucine, hypotaurine, serine, lysine, ethanolamine, choline and decreased creatine, creatinine, glutathione, ascorbate, glutamate, phosphoethanolamine and scyllo-inositol in all EC grades in reference to the non-transformed tissue. The increased levels of taurine was additionally detected in the G1 and G2 tumors in comparison to the control tissue, while the elevated glycine, <jats:italic>N<\/jats:italic>-acetyl compound and lactate\u2014in the G1 and G3 tumors. The metabolic features typical for the G1 tumors are the increased dimethyl sulfone, phosphocholine, and decreased glycerophosphocholine and glutamine levels, while the decreased myo-inositol level is characteristic for the G2 and G3 tumors. The elevated 3-hydroxybutyrate, alanine and betaine levels were observed in the G3 tumors. The differences between the grade G1 and G3 malignances were mainly related to the perturbations of phosphoethanolamine and phosphocholine biosynthesis, inositol, betaine, serine and glycine metabolism. The statistical significance of the OPLS-DA modeling was also verified by an univariate analysis. HR-MAS NMR based metabolomics provides an useful insight into the metabolic reprogramming in endometrial cancer.<\/jats:p>","DOI":"10.1038\/s41598-021-97505-y","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T10:04:04Z","timestamp":1631527444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Grading of endometrial cancer using 1H HR-MAS NMR-based metabolomics"],"prefix":"10.1038","volume":"11","author":[{"given":"Agnieszka","family":"Skorupa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Po\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Ciszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Cicho\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Klimek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Witek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Paku\u0142o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Boguszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sok\u00f3\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"key":"97505_CR1","unstructured":"Global Cancer Observatory. Gco.iarc.fr (2021). https:\/\/gco.iarc.fr\/."},{"key":"97505_CR2","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.3390\/ijms21176073","volume":"21","author":"S Kyo","year":"2020","unstructured":"Kyo, S. & Nakayama, K. Endometrial cancer as a metabolic disease with dysregulated PI3K signaling: Shedding light on novel therapeutic strategies. Int. J. Mol. Sci. 21, 6073 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"97505_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ygyno.2020.04.043","volume":"158","author":"S Kim","year":"2020","unstructured":"Kim, S. et al. Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification. Gynecol. Oncol. 158, 3\u201311 (2020).","journal-title":"Gynecol. Oncol."},{"key":"97505_CR4","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","volume":"31","author":"V Setiawan","year":"2013","unstructured":"Setiawan, V. et al. Type I and II endometrial cancers: Have they different risk factors?. J. Clin. Oncol. 31, 2607\u20132618 (2013).","journal-title":"J. Clin. Oncol."},{"key":"97505_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1089\/jwh.2018.6956","volume":"28","author":"G Constantine","year":"2019","unstructured":"Constantine, G., Kessler, G., Graham, S. & Goldstein, S. Increased incidence of endometrial cancer following the women\u2019s health initiative: An assessment of risk factors. J. Womens Health 28, 237\u2013243 (2019).","journal-title":"J. Womens Health"},{"key":"97505_CR6","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1097\/PGP.0000000000000518","volume":"38","author":"R Soslow","year":"2019","unstructured":"Soslow, R. et al. Endometrial carcinoma diagnosis. Int. J. Gynecol. Pathol. 38, S64\u2013S74 (2019).","journal-title":"Int. J. Gynecol. Pathol."},{"key":"97505_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ygyno.2006.03.006","volume":"103","author":"M Bowden","year":"2006","unstructured":"Bowden, M., Di Nezza-Cossens, L., Jobling, T., Salamonsen, L. & Nie, G. Serine proteases HTRA1 and HTRA3 are down-regulated with increasing grades of human endometrial cancer. Gynecol. Oncol. 103, 253\u2013260 (2006).","journal-title":"Gynecol. Oncol."},{"key":"97505_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/01.pas.0000152129.81363.d2","volume":"29","author":"A Alkushi","year":"2005","unstructured":"Alkushi, A. et al. Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems. Am. J. Surg. Pathol. 29, 295\u2013304 (2005).","journal-title":"Am. J. Surg. Pathol."},{"key":"97505_CR9","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1016\/S1470-2045(13)70591-6","volume":"15","author":"R Murali","year":"2014","unstructured":"Murali, R., Soslow, R. & Weigelt, B. Classification of endometrial carcinoma: More than two types. Lancet Oncol. 15, e268\u2013e278 (2014).","journal-title":"Lancet Oncol."},{"key":"97505_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40661-016-0035-4","volume":"3","author":"A Talhouk","year":"2016","unstructured":"Talhouk, A. & McAlpine, J. New classification of endometrial cancers: The development and potential applications of genomic-based classification in research and clinical care. Gynecol. Oncol. Res. Pract. 3, 20 (2016).","journal-title":"Gynecol. Oncol. Res. Pract."},{"key":"97505_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/his.14015","volume":"76","author":"L Vermij","year":"2019","unstructured":"Vermij, L., Smit, V., Nout, R. & Bosse, T. Incorporation of molecular characteristics into endometrial cancer management. Histopathology 76, 52\u201363 (2019).","journal-title":"Histopathology"},{"key":"97505_CR12","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/path.5373","volume":"250","author":"A Le\u00f3n-Castillo","year":"2020","unstructured":"Le\u00f3n-Castillo, A. et al. Clinicopathological and molecular characterisation of \u2018multiple-classifier\u2019 endometrial carcinomas. J. Pathol. 250, 312\u2013322 (2020).","journal-title":"J. Pathol."},{"key":"97505_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/metabo10080314","volume":"10","author":"K Njoku","year":"2020","unstructured":"Njoku, K., Sutton, C., Whetton, A. & Crosbie, E. Metabolomic biomarkers for detection, prognosis and identifying recurrence in endometrial cancer. Metabolites 10, 314 (2020).","journal-title":"Metabolites"},{"key":"97505_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s13167-018-0128-8","volume":"9","author":"M Lu","year":"2018","unstructured":"Lu, M. & Zhan, X. The crucial role of multiomic approach in cancer research and clinically relevant outcomes. EPMA J. 9, 77\u2013102 (2018).","journal-title":"EPMA J."},{"key":"97505_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/1477-3163.113622","volume":"12","author":"K Vermeersch","year":"2013","unstructured":"Vermeersch, K. & Styczynski, M. Applications of metabolomics in cancer research. J. Carcinog. 12, 9 (2013).","journal-title":"J. Carcinog."},{"key":"97505_CR16","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1097\/CM9.0000000000000286","volume":"132","author":"F Yin","year":"2019","unstructured":"Yin, F. et al. Intra-tumor heterogeneity for endometrial cancer and its clinical significance. Chin. Med. J. 132, 1550\u20131562 (2019).","journal-title":"Chin. Med. J."},{"key":"97505_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1534\/genetics.110.125724","volume":"188","author":"R Durrett","year":"2011","unstructured":"Durrett, R., Foo, J., Leder, K., Mayberry, J. & Michor, F. Intratumor heterogeneity in evolutionary models of tumor progression. Genetics 188, 461\u2013477 (2011).","journal-title":"Genetics"},{"key":"97505_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883\u2013892 (2012).","journal-title":"N. Engl. J. Med."},{"key":"97505_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00109-020-01874-2","volume":"98","author":"S Ram\u00f3n y Cajal","year":"2020","unstructured":"Ram\u00f3n y Cajal, S. et al. Clinical implications of intratumor heterogeneity: Challenges and opportunities. J. Mol. Med. 98, 161\u2013177 (2020).","journal-title":"J. Mol. Med."},{"key":"97505_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000475529","volume":"85","author":"S Gatius","year":"2017","unstructured":"Gatius, S. et al. Tumor heterogeneity in endometrial carcinoma: Practical consequences. Pathobiology 85, 35\u201340 (2017).","journal-title":"Pathobiology"},{"key":"97505_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2174\/9781608059621115010005","volume":"1","author":"A-HM Emwas","year":"2015","unstructured":"Emwas, A.-H.M., Merzaban, J. S. & Serrai, H. Theory and applications of NMR-based metabolomics in human disease diagnosis. Chapter 3 Appl. NMR Spectrosc. 1, 93\u2013130 (2015).","journal-title":"Chapter 3 Appl. NMR Spectrosc."},{"key":"97505_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41598-017-18435-2","volume":"8","author":"M Dutta","year":"2018","unstructured":"Dutta, M. et al. Metabolomics reveals perturbations in endometrium and serum of minimal and mild endometriosis. Sci. Rep. 8, 20 (2018).","journal-title":"Sci. Rep."},{"key":"97505_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fendo.2018.00087","volume":"9","author":"Y Audet-Delage","year":"2018","unstructured":"Audet-Delage, Y., Villeneuve, L., Gr\u00e9goire, J., Plante, M. & Guillemette, C. Identification of metabolomic biomarkers for endometrial cancer and its recurrence after surgery in postmenopausal women. Front. Endocrinol. 9, 20 (2018).","journal-title":"Front. Endocrinol."},{"key":"97505_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/metabo9020019","volume":"9","author":"M Gogiashvili","year":"2019","unstructured":"Gogiashvili, M. et al. HR-MAS NMR based quantitative metabolomics in breast cancer. Metabolites 9, 19 (2019).","journal-title":"Metabolites"},{"key":"97505_CR25","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1158\/0008-5472.CAN-13-2409","volume":"74","author":"S Trousil","year":"2014","unstructured":"Trousil, S. et al. Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway. Can. Res. 74, 6867\u20136877 (2014).","journal-title":"Can. Res."},{"key":"97505_CR26","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1093\/bioinformatics\/bti300","volume":"21","author":"J Wong","year":"2005","unstructured":"Wong, J., Cagney, G. & Cartwright, H. SpecAlign\u2013processing and alignment of mass spectra datasets. Bioinformatics 21, 2088\u20132090 (2005).","journal-title":"Bioinformatics"},{"key":"97505_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1021\/ac0713510","volume":"80","author":"S Wiklund","year":"2008","unstructured":"Wiklund, S. et al. Visualization of GC\/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal. Chem. 80, 115\u2013122 (2008).","journal-title":"Anal. Chem."},{"key":"97505_CR28","doi-asserted-by":"publisher","first-page":"W486","DOI":"10.1093\/nar\/gky310","volume":"46","author":"J Chong","year":"2018","unstructured":"Chong, J. et al. MetaboAnalyst 4.0: Towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 46, W486\u2013W494 (2018).","journal-title":"Nucleic Acids Res."},{"key":"97505_CR29","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkp1002","volume":"38","author":"A Frolkis","year":"2009","unstructured":"Frolkis, A. et al. SMPDB: The small molecule pathway database. Nucleic Acids Res. 38, D480\u2013D487 (2009).","journal-title":"Nucleic Acids Res."},{"key":"97505_CR30","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.bbalip.2011.09.009","volume":"1821","author":"L Cole","year":"2012","unstructured":"Cole, L., Vance, J. & Vance, D. Phosphatidylcholine biosynthesis and lipoprotein metabolism. Biochim. Biophys. Acta Mol. Cell Biol. Lip. 1821, 754\u2013761 (2012).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lip."},{"key":"97505_CR31","first-page":"1097","volume":"18","author":"W Albrecht","year":"2019","unstructured":"Albrecht, W. Highlight report: Role of choline phospholipid metabolism in tumor progression. EXCLI J. 18, 1097\u20131098 (2019).","journal-title":"EXCLI J."},{"key":"97505_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fonc.2016.00266","volume":"6","author":"M Cheng","year":"2016","unstructured":"Cheng, M., Bhujwalla, Z. & Glunde, K. Targeting phospholipid metabolism in cancer. Front. Oncol. 6, 20 (2016).","journal-title":"Front. Oncol."},{"key":"97505_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/nbm.4112","volume":"32","author":"K Sonkar","year":"2019","unstructured":"Sonkar, K. et al. Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer. NMR Biomed. 32, 20 (2019).","journal-title":"NMR Biomed."},{"key":"97505_CR34","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1177\/0284185117733297","volume":"59","author":"S Ytre-Hauge","year":"2017","unstructured":"Ytre-Hauge, S. et al. In vivo MR spectroscopy predicts high tumor grade in endometrial cancer. Acta Radiol. 59, 497\u2013505 (2017).","journal-title":"Acta Radiol."},{"key":"97505_CR35","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/cas.13532","volume":"109","author":"K Shi","year":"2018","unstructured":"Shi, K. et al. Identification and functional analyses of differentially expressed metabolites in early stage endometrial carcinoma. Cancer Sci. 109, 1032\u20131043 (2018).","journal-title":"Cancer Sci."},{"key":"97505_CR36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11306-019-1609-z","volume":"15","author":"S Cheng","year":"2019","unstructured":"Cheng, S. et al. Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy. Metabolomics 15, 2 (2019).","journal-title":"Metabolomics"},{"key":"97505_CR37","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/nbm.2766","volume":"25","author":"M Cao","year":"2012","unstructured":"Cao, M. et al. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer. NMR Biomed. 25, 1033\u20131042 (2012).","journal-title":"NMR Biomed."},{"key":"97505_CR38","doi-asserted-by":"publisher","first-page":"9369","DOI":"10.1158\/0008-5472.CAN-05-1146","volume":"65","author":"E Iorio","year":"2005","unstructured":"Iorio, E. et al. Alterations of choline phospholipid metabolism in ovarian tumor progression. Can. Res. 65, 9369\u20139376 (2005).","journal-title":"Can. Res."},{"key":"97505_CR39","doi-asserted-by":"publisher","first-page":"e0222353","DOI":"10.1371\/journal.pone.0222353","volume":"14","author":"X Cui","year":"2019","unstructured":"Cui, X. et al. Differential metabolomics networks analysis of menopausal status. PLoS\u00a0One 14, e0222353 (2019).","journal-title":"PLoS\u00a0One"},{"key":"97505_CR40","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/ajcn\/85.5.1275","volume":"85","author":"L Fischer","year":"2007","unstructured":"Fischer, L. et al. Sex and menopausal status influence human dietary requirements for the nutrient choline. Am. J. Clin. Nutr. 85, 1275\u20131285 (2007).","journal-title":"Am. J. Clin. Nutr."},{"key":"97505_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.celrep.2019.08.087","volume":"29","author":"T Osawa","year":"2019","unstructured":"Osawa, T. et al. Phosphoethanolamine accumulation protects cancer cells under glutamine starvation through downregulation of PCYT2. Cell Rep. 29, 89-103.e7 (2019).","journal-title":"Cell Rep."},{"key":"97505_CR42","doi-asserted-by":"publisher","first-page":"e3936","DOI":"10.1002\/nbm.3936","volume":"31","author":"T Shah","year":"2018","unstructured":"Shah, T. et al. Molecular causes of elevated phosphoethanolamine in breast and pancreatic cancer cells. NMR Biomed. 31, e3936 (2018).","journal-title":"NMR Biomed."},{"key":"97505_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40170-018-0178-3","volume":"6","author":"P Viswanath","year":"2018","unstructured":"Viswanath, P. et al. Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner. Cancer Metab. 6, 20 (2018).","journal-title":"Cancer Metab."},{"key":"97505_CR44","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.tibs.2014.02.004","volume":"39","author":"I Amelio","year":"2014","unstructured":"Amelio, I., Cutruzzol\u00e1, F., Antonov, A., Agostini, M. & Melino, G. Serine and glycine metabolism in cancer. Trends Biochem. Sci. 39, 191\u2013198 (2014).","journal-title":"Trends Biochem. Sci."},{"key":"97505_CR45","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1158\/2159-8290.CD-14-0250","volume":"4","author":"J Ye","year":"2014","unstructured":"Ye, J. et al. Serine catabolism regulates mitochondrial redox control during hypoxia. Cancer Discov. 4, 1406\u20131417 (2014).","journal-title":"Cancer Discov."},{"key":"97505_CR46","doi-asserted-by":"publisher","first-page":"11004","DOI":"10.18632\/oncotarget.2668","volume":"5","author":"A Antonov","year":"2014","unstructured":"Antonov, A. et al. Bioinformatics analysis of the serine and glycine pathway in cancer cells. Oncotarget 5, 11004\u201311013 (2014).","journal-title":"Oncotarget"},{"key":"97505_CR47","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1158\/2159-8290.CD-14-1228","volume":"4","author":"I Mart\u00ednez-Reyes","year":"2014","unstructured":"Mart\u00ednez-Reyes, I. & Chandel, N. Mitochondrial one-carbon metabolism maintains redox balance during hypoxia. Cancer Discov. 4, 1371\u20131373 (2014).","journal-title":"Cancer Discov."},{"key":"97505_CR48","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.celrep.2014.04.045","volume":"7","author":"C Labuschagne","year":"2014","unstructured":"Labuschagne, C., van den Broek, N., Mackay, G., Vousden, K. & Maddocks, O. Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. Cell Rep. 7, 1248\u20131258 (2014).","journal-title":"Cell Rep."},{"key":"97505_CR49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.semcdb.2015.08.002","volume":"43","author":"Z Tsun","year":"2015","unstructured":"Tsun, Z. & Possemato, R. Amino acid management in cancer. Semin. Cell Dev. Biol. 43, 22\u201332 (2015).","journal-title":"Semin. Cell Dev. Biol."},{"key":"97505_CR50","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3390\/molecules25071720","volume":"25","author":"F Omoruyi","year":"2020","unstructured":"Omoruyi, F., Stennett, D., Foster, S. & Dilworth, L. New frontiers for the use of IP6 and inositol combination in treating diabetes mellitus: A review. Molecules 25, 1720 (2020).","journal-title":"Molecules"},{"key":"97505_CR51","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bpobgyn.2016.03.007","volume":"37","author":"A Bevilacqua","year":"2016","unstructured":"Bevilacqua, A. & Bizzarri, M. Physiological role and clinical utility of inositols in polycystic ovary syndrome. Best Pract. Res. Clin. Obstet. Gynaecol. 37, 129\u2013139 (2016).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"97505_CR52","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/BF01204248","volume":"9","author":"T Chiu","year":"1992","unstructured":"Chiu, T. & Tam, P. A correlation of the outcome of clinical in vitro fertilization with the inositol content and embryotrophic properties of human serum. J. Assist. Reprod. Genet. 9, 524\u2013530 (1992).","journal-title":"J. Assist. Reprod. Genet."},{"key":"97505_CR53","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1021\/pr200147g","volume":"10","author":"Y Hua","year":"2011","unstructured":"Hua, Y. et al. Dynamic metabolic transformation in tumor invasion and metastasis in mice with LM-8 osteosarcoma Cell transplantation. J. Proteome Res. 10, 3513\u20133521 (2011).","journal-title":"J. Proteome Res."},{"key":"97505_CR54","doi-asserted-by":"publisher","first-page":"38541","DOI":"10.18632\/oncotarget.15872","volume":"8","author":"L Ren","year":"2017","unstructured":"Ren, L. et al. Metabolomics uncovers a link between inositol metabolism and osteosarcoma metastasis. Oncotarget 8, 38541\u201338553 (2017).","journal-title":"Oncotarget"},{"key":"97505_CR55","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/nature07762","volume":"457","author":"A Sreekumar","year":"2009","unstructured":"Sreekumar, A. et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910\u2013914 (2009).","journal-title":"Nature"},{"key":"97505_CR56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnut.2018.00061","volume":"5","author":"S Sivanesan","year":"2018","unstructured":"Sivanesan, S., Taylor, A., Zhang, J. & Bakovic, M. Betaine and choline improve lipid homeostasis in obesity by participation in mitochondrial oxidative demethylation. Front. Nutr. 5, 20 (2018).","journal-title":"Front. Nutr."},{"key":"97505_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fimmu.2018.00020","volume":"9","author":"G Zhao","year":"2018","unstructured":"Zhao, G. et al. Betaine in inflammation: Mechanistic aspects and applications. Front. Immunol. 9, 20 (2018).","journal-title":"Front. Immunol."},{"key":"97505_CR58","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jphs.2016.04.022","volume":"131","author":"R Nishiyama","year":"2016","unstructured":"Nishiyama, R. et al. Identification and functional analysis of choline transporter in tongue cancer: A novel molecular target for tongue cancer therapy. J. Pharmacol. Sci. 131, 101\u2013109 (2016).","journal-title":"J. Pharmacol. Sci."},{"key":"97505_CR59","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s10147-013-0565-2","volume":"19","author":"Y Ihata","year":"2013","unstructured":"Ihata, Y. et al. Amino acid profile index for early detection of endometrial cancer: Verification as a novel diagnostic marker. Int. J. Clin. Oncol. 19, 364\u2013372 (2013).","journal-title":"Int. J. Clin. Oncol."},{"key":"97505_CR60","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/MCO.0000000000000430","volume":"21","author":"E Ananieva","year":"2018","unstructured":"Ananieva, E. & Wilkinson, A. Branched-chain amino acid metabolism in cancer. Curr. Opin. Clin. Nutr. Metab. Care 21, 64\u201370 (2018).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"97505_CR61","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/ijc.30371","volume":"139","author":"A Marshall","year":"2016","unstructured":"Marshall, A. et al. LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma. Int. J. Cancer 139, 2529\u20132539 (2016).","journal-title":"Int. J. Cancer"},{"key":"97505_CR62","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1038\/oncsis.2017.70","volume":"6","author":"A Marshall","year":"2017","unstructured":"Marshall, A. et al. ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma. Oncogenesis 6, e367\u2013e367 (2017).","journal-title":"Oncogenesis"},{"key":"97505_CR63","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ygyno.2020.05.383","volume":"159","author":"S Asaka","year":"2020","unstructured":"Asaka, S. et al. Glutaminase expression is correlated with adverse clinicopathological features and patient outcome in endometrial cancer. Gynecol. Oncol. 159, 229 (2020).","journal-title":"Gynecol. Oncol."},{"key":"97505_CR64","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1006\/gyno.1996.0038","volume":"60","author":"M Ohwada","year":"1996","unstructured":"Ohwada, M., Suzuki, M., Sato, I., Tsukamoto, H. & Watanabe, K. Glutathione peroxidase activity in endometrium: Effects of sex hormones and cancer. Gynecol. Oncol. 60, 277\u2013282 (1996).","journal-title":"Gynecol. Oncol."},{"key":"97505_CR65","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/cncr.10774","volume":"95","author":"E Sivridis","year":"2002","unstructured":"Sivridis, E., Giatromanolaki, A., Gatter, K., Harris, A. & Koukourakis, M. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer 95, 1055\u20131063 (2002).","journal-title":"Cancer"},{"key":"97505_CR66","doi-asserted-by":"publisher","first-page":"5749","DOI":"10.1158\/0008-5472.CAN-10-0263","volume":"70","author":"C Kuiper","year":"2010","unstructured":"Kuiper, C. et al. Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer. Can. Res. 70, 5749\u20135758 (2010).","journal-title":"Can. Res."},{"key":"97505_CR67","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1042\/BSR20180185","volume":"38","author":"Y Al-Mutawa","year":"2018","unstructured":"Al-Mutawa, Y. et al. Effects of hypoxic preconditioning on neuroblastoma tumour oxygenation and metabolic signature in a chick embryo model. Biosci. Rep. 38, 20 (2018).","journal-title":"Biosci. Rep."},{"key":"97505_CR68","doi-asserted-by":"publisher","first-page":"5281","DOI":"10.1021\/pr500629t","volume":"13","author":"X He","year":"2014","unstructured":"He, X. & Slupsky, C. Metabolic fingerprint of dimethyl sulfone (DMSO2) in microbial-mammalian co-metabolism. J. Proteome Res. 13, 5281\u20135292 (2014).","journal-title":"J. Proteome Res."},{"key":"97505_CR69","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10565-020-09542-4","volume":"37","author":"K Kowalska","year":"2020","unstructured":"Kowalska, K. et al. Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin. Cell Biol. Toxicol. 37, 261\u2013275 (2020).","journal-title":"Cell Biol. Toxicol."},{"key":"97505_CR70","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41598-017-09169-2","volume":"7","author":"T Altadill","year":"2017","unstructured":"Altadill, T. et al. Metabolomic and lipidomic profiling identifies the role of the RNA editing pathway in endometrial carcinogenesis. Sci. Rep. 7, 20 (2017).","journal-title":"Sci. Rep."},{"key":"97505_CR71","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/humrep\/dew003","volume":"31","author":"E Subramani","year":"2016","unstructured":"Subramani, E. et al. NMR-based metabonomics for understanding the influence of dormant female genital tuberculosis on metabolism of the human endometrium. Hum. Reprod. 31, 854\u2013865 (2016).","journal-title":"Hum. Reprod."},{"key":"97505_CR72","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.3390\/molecules25215128","volume":"25","author":"A Crook","year":"2020","unstructured":"Crook, A. & Powers, R. Quantitative NMR-based biomedical metabolomics: Current status and applications. Molecules 25, 5128 (2020).","journal-title":"Molecules"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97505-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97505-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97505-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T15:42:31Z","timestamp":1670082151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97505-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["97505"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-97505-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]},"assertion":[{"value":"7 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18160"}}